XML 18 R25.htm IDEA: XBRL DOCUMENT v2.4.0.6
NOTE 19 - SEGMENT AND RELATED INFORMATION
12 Months Ended
Jun. 30, 2012
Segment Reporting [Abstract]  
NOTE 19 - SEGMENT AND RELATED INFORMATION

NOTE 19 - SEGMENT AND RELATED INFORMATION

 

The Company provides segment data in accordance with the provisions of ASC topic 280, “Disclosures about Segments of an Enterprise and Related Information”.

 

The Company operates in two industry segments - manufacturing and the servicing of medical equipment and management of diagnostic imaging centers.

 

The accounting policies of the segments are the same as those described in the summary of significant accounting policies. All intersegment sales are market-based. The Company evaluates performance based on income or loss from operations.

 

Summarized financial information concerning the Company’s reportable segments is shown in the following table:

 

   Manufacturing and Servicing of Medical Equipment  Management of Diagnostic Imaging Centers  Totals
Fiscal 2012:                
Net revenues from external customers  $18,707,006   $20,737,413   $39,444,419 
Intersegment net revenues  $810,000   $—     $810,000 
Income from operations  $2,666,574   $4,539,977   $7,206,551 
Depreciation and amortization  $697,100   $1,533,150   $2,230,250 
Compensatory element of stock issuances  $155,068   $25,350   $180,418 
Total identifiable assets  $15,144,291   $18,471,177   $33,615,468 
Capital expenditures  $404,530   $822,842   $1,227,372 
Fiscal 2011:               
Net revenues from external customers  $17,811,636   $15,324,759   $33,136,395 
Intersegment net revenues  $924,166   $—     $924,166 
Income from operations  $1,433,331   $2,358,138   $3,791,469 
Depreciation and amortization  $806,117   $1,266,889   $2,073,006 
Compensatory element of stock issuances  $139,308   $65,178   $204,486 
Total identifiable assets  $13,439,701   $18,140,973   $31,580,674 
Capital expenditures  $202,468   $532,562   $735,030 

 

Export Product Sales

 

The Company’s areas of operations are principally in the United States. The Company had export sales of medical equipment amounting to 17.0% and 28.0% of product sales revenues to third parties for the years ended June 30, 2012 and 2011, respectively.

 

The foreign product sales, as a percentage of product sales to unrelated parties, were made to customers in the following countries:

 

   For the Years Ended June 30,
   2012  2011
Holland   0.1%   - % 
England   16.9    —   
Germany   —      19.5 
Greece   —      5.8 
Australia   —      0.7 
Puerto Rico   —      0.9 
Libya   —      1.1 
    17.0%   28.0%

 

 

Foreign Service and Repair Fees

 

The Company’s areas of service and repair are principally in the United States. The Company had foreign revenues of service and repair of medical equipment amounting to 9.9% and 7.8% of consolidated net service and repair fees for the years ended June 30, 2012 and 2011, respectively. The foreign service and repair fees, as a percentage of total service and repair fees, were provided principally to the following countries:

 

   For the Years Ended June 30,
   2012  2011
Spain   0.8%   1.1%
Puerto Rico   0.9    1.0 
Switzerland   1.0    0.5 
Germany   0.3    0.3 
England   1.8    1.7 
Holland   2.6    1.3 
Scotland   0.7    0.9 
Canada   0.8    0.3 
Australia   0.4    0.4 
Libya   0.2    0.3 
Greece   0.4    —   
    9.9%   7.8%

 

The Company does not have any material assets outside of the United States.